| 000 | 01120nam a22003137a 4500 | ||
|---|---|---|---|
| 003 | PH-MaWHO | ||
| 005 | 20260331151329.0 | ||
| 008 | 260331b |||||||| |||| 00| 0 eng d | ||
| 020 | _a9241592362 | ||
| 020 | _a9789241592369 | ||
| 040 | _cWPRO Library | ||
| 041 | _aeng | ||
| 090 | _aWC 503.1 2002WO | ||
| 110 |
_aWorld Health Organization. Department of Essential Health Technologies. _9661008 |
||
| 245 |
_aHIV assays : _boperational characteristics (Phase 1) : report 13 : urine specimens, oral fluid (saliva) specimens. |
||
| 264 |
_aGeneva : _bWorld Health Organization, _c2002. |
||
| 300 | _a30 pages. | ||
| 590 | _aHSI | ||
| 650 |
_aAIDS serodiagnosis _xMethods _9371881 |
||
| 650 |
_aUrine--Virology _9661009 |
||
| 650 |
_aSaliva--Virology _9661010 |
||
| 650 |
_aEnzyme-linked immunosorbent assay _9148621 |
||
| 650 |
_aBlotting, Western _9365614 |
||
| 650 |
_aClinical trials, Phase I _9660708 |
||
| 650 |
_aReagent kits, Diagnostic _9298428 |
||
| 710 |
_aUNAIDS. _9650736 |
||
| 856 | _uhttps://iris.who.int/handle/10665/43056 | ||
| 942 |
_cMONO _b2017 retain _gMark 16-05-2018 15:43:56 _2nml |
||
| 999 |
_c10123 _d10123 |
||